For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely cyclooxygenase-2 and COX-2.
Scope of the Report:
This report focuses on the Etoricoxib Intermediate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Some of the NSAIDs can be used in a single dose to treat various types of pain; it can also be used for post-surgical pains.
The worldwide market for Etoricoxib Intermediate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Sun Pharmaceutical
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- n-House Manufacturing
- Contract Manufacturing Organizations
Market Segment by Applications, can be divided into
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Chronic Low Back Pain
- Acute Pain
There are 15 Chapters to deeply display the global Etoricoxib Intermediate market.
Chapter 1, to describe Etoricoxib Intermediate Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Etoricoxib Intermediate, with sales, revenue, and price of Etoricoxib Intermediate, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Etoricoxib Intermediate, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Etoricoxib Intermediate market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Etoricoxib Intermediate sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source